ライフサイエンスコーパス: post partum

1 early infant mortality (deaths until 90 days post partum).

2 rying time of onset throughout pregnancy and post partum.

3 estation through planned weaning by 6 months post partum.

4 tionnaire at the last 4 pregnancy visits and post partum.

5 ps were returned to standard laboratory chow post partum.

6 two groups of women at 6 weeks and 6 months post partum.

7 daily, every month from enrolment to 90 days post partum.

8 l, and economic indicators in the first year post partum.

9 to postnatal day 1 and resolution by 2 weeks post partum.

10 men who received Tdap vaccine within 14 days post partum.

11 nal protocol) from enrollment until 24 hours post partum.

12 mother and baby, but it resolves completely post partum.

13 artum diabetes was excluded at 4 to 16 weeks post partum.

14 e in the maternal circulation for many years post partum.

15 were enrolled a mean (+/-SD) of 16+/-2 days post partum.

16 ctating women were enrolled 5.6+/-0.8 months post partum.

17 study period; 797 of the women were pregnant/post partum.

18 ch are associated with long-term morbidities post partum.

19 150 vs 11 [7%] of 168 pairs; 10.3, 5.4-19.7) post partum.

20 ceptance of proposed services up to 6 weeks' post partum.

21 partum, and for about 75% during months 4-21 post partum.

22 arget of 50 ng/mL, both during pregnancy and post partum.

23 tosis and are expected to resolve or improve post partum.

24 tum women and women who were not pregnant or post partum.

25 of the nipple can be symptomatic and persist post partum.

26 ed with age in hours over the first few days post partum.

27 ion to delivery and followed for four months post-partum.

28 during pregnancy or in the first four months post-partum.

29 pregnancy but significantly decreased 1 day post-partum.

30 of the nascent epithelium at the forth week post-partum.

31 easome were restored to normal levels 7 days post-partum.

32 abnormalities and died between 7 and 21 days post-partum.

33 the catchment area for follow-up of 28 days post-partum.

34 al admissions for the child within 24 months post-partum.

35 raphy at baseline and at 2, 6, and 12 months post-partum.

36 mine than spermidine, except for the 5th day post-partum.

37 followed 100 women with PPCM through 1 year post-partum.

38 ing levels up to 4.41 mumol/l on the 3rd day post-partum.

39 at the 1st, 2nd, 3rd, 4th, 5th and 15th day post-partum.

40 ction at presentation and at 6 and 12 months post-partum.

41 en BM at week 1 (n = 10) and 4 weeks (n = 9) post-partum.

42 (E17-19, 173.7 %) fetal and neonatal (1 day post partum, 161 %) TG+ compared with transgenic negativ

43 At 6 weeks' post partum, 174 participants in the intervention group

44 More episodes began post partum (40.1%), followed by during pregnancy (33.4%

45 ove prepregnancy weight, 7.8 kg; mean months post partum, 5.2 months) randomized to the intervention

46 ation) and late (32-36 weeks) pregnancy, and post-partum (6-10 weeks after delivery).

47 ng antiretroviral treatment 6 months or more post partum (7.8% and 12.0%, respectively; P=0.39).

48 By 32 weeks post partum, 96% of women in the intervention groups and

49 all-cause neonatal mortality within 28 days post-partum among babies who survived the first 24 h of

50 rson-years in women who were not pregnant or post partum and 11.8 (8.4-15.3) per 1000 person-years in

51 18.9-22.4) in women who were not pregnant or post partum and 8.2 (5.7-11.8) in pregnant or post-partu

52 Plasma samples were obtained 10 days post partum and analyzed for resistance mutations.

53 t normal elastic fibers in the uterine tract post partum and develop pelvic organ prolapse, enlarged

54 essed included retention in care at 6 weeks' post partum and uptake of PMTCT services, measured by at

55 all-cause neonatal mortality within 28 days post-partum and all-cause neonatal mortality within 28 d

56 the hyaloid vessels are persistent at 8 days post-partum and the retinal vasculature overgrows.

57 pubertal development (between days 23 and 30 post partum) and independently of the presence of testos

58 ing pregnancy, for 66% in the first 3 months post partum, and for about 75% during months 4-21 post p

59 men with a second pregnancy within 24 months post-partum, and emergency attendances and hospital admi

60 rigin persistent in the maternal circulation post-partum are associated with protection against invas

61 nts retained in care at 6 weeks and 12 weeks post partum (assessed by generalised linear mixed effect

62 lent to oxytocin when used to stop excessive post-partum bleeding suspected to be due to uterine aton

63 visits were made during pregnancy and early post partum by peer counsellors recruited from the same

64 women were offered screening at 4 to 6 weeks post partum by telephone.

65 Three had myocarditis, 4 had post-partum cardiomyopathy (PPCM), and 1 had idiopathic

66 result of self-test distribution: two in the post-partum care group and two female sex workers.

67 were enrolled (61 in antenatal care, 117 in post-partum care, and 102 female sex workers); follow-up

68 cipants in antenatal care, two (2%) of 91 in post-partum care, and 41 (14%) of 298 from female sex wo

69 of 53 in antenatal care, 62 (68%) of 91 from post-partum care, and 53 (83%) of 64 female sex workers.

70 ipants in antenatal care, 91 (86%) of 106 in post-partum care, and 64 (75%) of 85 female sex workers.

71 prepregnancy, antenatal, labour, birth, and post-partum care, and family planning.

72 ction of weather metrics, to assess pre- and post-partum climatic influences on survival on herds in

73 Kenya: a health facility with antenatal and post-partum clinics and a drop-in centre for female sex

74 B-myb expression decreases at day 18 post partum, coincident with the initial appearance of l

75 vely had a relapse within the first 6 months post partum compared with 29 women (24.2%) who intended

76 ficantly reduced depression levels 12 months post partum compared with a control.

77 n increased stroke risk during pregnancy and post partum compared with their nonpregnant contemporari

78 tients (</=6 months post partum) with severe post-partum depression (Hamilton Rating Scale for Depres

79 Post-partum depression is a serious mood disorder in wom

80 nvestigation of brexanolone in patients with post-partum depression is in progress.

81 INTERPRETATION: In women with severe post-partum depression, infusion of brexanolone resulted

82 acid (GABAA) receptors, for the treatment of post-partum depression.

83 e development of therapies for patients with post-partum depression.

84 nal and caesarean deliveries, from triage to post-partum discharge) and breast cancer care (diagnosis

85 Transcription ceases in the ovary by 3 days post partum (dpp), but continues in the testis through a

86 he height in meters] of 25 to 30) at 4 weeks post partum either to restrict their energy intake by 50

87 isease is more common in women than men, and post partum exacerbation of thyroiditis is common.

88 At 3 months post partum, exclusive breastfeeding was practised by 67

89 st report of persistent Y chromosomal DNA in post-partum female dogs and these results suggest that f

90 detectable in blood samples obtained 10 days post partum from 32 percent of the women who had receive

91 In this pilot study on umbilical cords post partum from healthy non-obese (BMI = 19-25; n = 7)

92 nly 32% of 244 women followed to four months post-partum had attended an HIV clinic and been assessed

93 tum haemorrhage (1.49, 1.01-2.20; I(2)=37%), post-partum haemorrhage (1.29, 1.13-1.49; I(2)=41%), hyp

94 d antibiotics to reduce maternal deaths from post-partum haemorrhage and sepsis could be a highly eff

95 timates from published work of occurrence of post-partum haemorrhage and sepsis, case fatality, and t

96 978 (10%) women were diagnosed with primary post-partum haemorrhage and were randomly assigned to re

97 809 (3%) women were diagnosed with post-partum haemorrhage and were randomly assigned to re

98 ous to intravenous oxytocin for treatment of post-partum haemorrhage in women not exposed to oxytocin

99 ior to intravenous oxytocin for treatment of post-partum haemorrhage in women receiving prophylactic

100 he key events leading to maternal death from post-partum haemorrhage or sepsis after delivery.

101 estimated that of 2860 maternal deaths from post-partum haemorrhage or sepsis per year in Malawi, in

102 ning, could reduce maternal mortality due to post-partum haemorrhage or sepsis.

103 Deaths from post-partum haemorrhage peaked 2-3 h after childbirth.

104 on of women in the placebo group with severe post-partum haemorrhage than those in the cholecalcifero

105 acid in acute severe bleeding (traumatic and post-partum haemorrhage).

106 tocin, the standard of care for treatment of post-partum haemorrhage, is not available in all setting

107 Oxytocin, the gold-standard treatment for post-partum haemorrhage, needs refrigeration, intravenou

108 ics reduce death from bleeding in trauma and post-partum haemorrhage.

109 uitable first-line treatment alternative for post-partum haemorrhage.

110 Retained placenta is associated with post-partum haemorrhage.

111 mental and caesarean births, infections, and post-partum haemorrhage.

112 labour and delivery, and are more at risk of post-partum haemorrhage.

113 in view of its relevance in time-to-death in post-partum haemorrhage.

114 is increasingly used ad hoc for treatment of post-partum haemorrhage; however, evidence is insufficie

115 Maternal depression (antepartum or post partum) has been linked to negative health-related

116 s in pregnancy, neonatal thyrotoxicosis, and post-partum hyperthyroidism.

117 The lesions persisted post partum in 22 patients (88%).

118 NVP resistance mutations at day 10 or week 6 post partum in each arm was compared with that of a hist

119 ately 0.5 kg per week between 4 and 14 weeks post partum in overweight women who are exclusively brea

120 008, to June 30, 2012, with 1 year follow-up post partum in the nationwide German MS and pregnancy re

121 Additional studies are needed to examine the post-partum increase in viremia.

122 At 2 weeks post partum, initial intervention materials appropriate

123 At 1 day post-partum, lactationally active, distended lobuloalveo

124 ral phenotypes of EL mice are dependent upon post-partum maternal care which if systematically enhanc

125 n 31 mother-infant dyads within the first 15 post-partum months utilizing peptide microarray.

126 At 6 months post-partum, mothers were asked if they had experienced

127 (n22) and repeated during lactation 12 weeks post-partum (n14) and twice in NPNL women (n23 and n10,

128 Nine women died between 2 weeks and 48 weeks post partum (one in maternal-antiretroviral group, two i

129 emerged as prominent symptom dimensions with post-partum onset and were notably severe.

130 ternal complications occurring up to 6 weeks post partum or until hospital discharge, whichever was l

131 (p = 0.001), and presentation after 6 weeks post-partum (p = 0.02) were associated with a lower LVEF

132 e immediately after birth (P0) or at 10 days post partum (P10) to determine whether neural responses

133 acute neurological symptoms in pregnant and post-partum patients is likely to improve as we learn mo

134 hyperthyroidism in pregnancy and during the post-partum period are special circumstances that need c

135 associated with HIV during pregnancy and the post-partum period in sub-Saharan Africa.

136 The post-partum period represents an important opportunity t

137 breastfeeding and history of low mood in the post-partum period.

138 that developed in the intrapartum and early post-partum period.

139 reful attention throughout pregnancy and the post-partum period.

140 severe mental disorders in pregnancy and the post-partum period.

141 en died, 235 of them during pregnancy or the post-partum period.

142 inatal depression (ie, during antepartum and post-partum periods) among women residing in low-income

143 occurs endogenously during pre-menstrual and post-partum periods, when decreased response to BDZ has

144 intervention should include preconception or post-partum periods.

145 of symptom onset within pregnancy and three post-partum periods.

146 Pregnant or post-partum person-years were calculated for HIV-infecte

147 stage, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7).

148 ii) one day post-partum (PP1) and iv) 7 days post-partum (PP7).

149 e available during pregnancy and immediately post partum, pregnancy-related loss of maternal renal fu

150 By 5 days post-partum, prominent expression became restricted to m

151 and those with the onset of new episodes of post-partum psychosis.

152 ression was significantly increased by day 1 post partum, reaching levels greater than those normally

153 ens of HAART from pregnancy through 6 months post partum resulted in high rates of virologic suppress

154 Post-partum surgical complications and prolonged hospita

155 thdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model.

156 xpression of milk proteins, and by two weeks post-partum their pups are smaller in size.

157 tained from the mothers weekly until 4 weeks post partum then monthly.

158 dies; however, whether treatment can prevent post-partum thyroiditis in women who are or have been an

159 Post-partum thyroiditis is substantially more frequent i

160 Post-partum thyroiditis occurs in 5-10% of women, and ma

161 e objective of this study was to monitor the post-partum variation of polyamine content, in ovine and

162 maternal mood between delivery and 6 months post-partum was associated with an increased risk of inf

163 of blood glucose, and increased attention to post-partum weight management.

164 occurring during pregnancy and up to 42 days post partum were defined as pregnancy related.

165 nown HIV status who died during pregnancy or post partum were HIV infected.

166 0 and an LVEDD >/=6.0 cm recovered by 1 year post-partum, whereas 91% with both a baseline LVEF >/=0.

167 cian-referred female inpatients (</=6 months post partum) with severe post-partum depression (Hamilto

168 ected data prospectively for all pregnant or post-partum women admitted to the obstetric department.

169 able rates were compared between pregnant or post-partum women and women who were not pregnant or pos

170 ct that roughly 24% of deaths in pregnant or post-partum women are attributable to HIV in sub-Saharan

171 Acute neurological symptoms in pregnant and post-partum women could be caused by exacerbation of a p

172 HIV-infected pregnant or post-partum women had around eight times higher mortalit

173 4-15.3) per 1000 person-years in pregnant or post-partum women.

174 ion to the needs of HIV-infected pregnant or post-partum women.

175 ost partum and 8.2 (5.7-11.8) in pregnant or post-partum women.